Skip to content
ppharmaranks
Menu
Pacira Pharms Inc logo

depocyt

Pharmaranks rates Depocyt 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Depocyt (Cytarabine) is a nucleoside metabolic inhibitor used to treat Leukemia, Lymphoma, Meningeal Neoplasms.

Cytarabine · by Pacira Pharms Inc

Available as a generic: Cytarabine

70/100Limited · 1 source

Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate
Verified againstopenFDANIH DailyMedRxClass

Key facts

Active ingredient
Cytarabine
Form
Injectable, Liposomal
Strength
Cytarabine 10MG/ML
Type
Prescription (Rx)
Brand or generic
Brand-name
Manufacturer
Pacira Pharms Inc
FDA application
NDA021041
Availability
Discontinued (per FDA)

Drug class

How this class works, per Gemcitabine — LiverTox, NCBI Bookshelf (NIH).

May treat (source: NIH RxClass)

Dosage forms

Injectable and Liposomal

The forms currently marketed in the U.S., per the FDA National Drug Code Directory.

Ways to save

Ask for the generic

Same active ingredient, far cheaper. Is there a generic? →

Request a 90-day supply

Bulk fills usually lower the per-dose price vs monthly refills.

Use copay cards

Manufacturer copay cards & patient-assistance programs — especially for brand drugs.

Compare alternatives

A same-class option may cost less. See alternatives →

Frequently asked questions

What does Depocyt treat?
Depocyt (Cytarabine) may be used to treat leukemia, lymphoma, meningeal neoplasms, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
How does Depocyt work?
Depocyt is a nucleoside metabolic inhibitor. Nucleoside metabolic inhibitors are fake DNA building blocks that fast-dividing cancer cells mistake for the real thing. Once inside, they get incorporated into the cell's DNA and also block enzymes such as ribonucleotide reductase, which together halt DNA copying and cause the cancer cell to die.
How is Depocyt rated?
pharmaranks gives Depocyt a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
Is there a coupon or discount for Depocyt?
pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Depocyt. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
Who makes Depocyt?
Depocyt is marketed by Pacira Pharms Inc. You can see Pacira Pharms Inc's full profile, rating, and other products on pharmaranks.
Is Depocyt a brand-name or generic drug?
Depocyt is a brand-name product with the active ingredient Cytarabine. Lower-cost generic equivalents containing Cytarabine are available — ask your pharmacist.
Is Depocyt available over the counter?
No. Depocyt is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
What forms does Depocyt come in?
Depocyt is currently marketed as injectable and liposomal, per the FDA's National Drug Code Directory.
What class of drug is Depocyt?
Depocyt is classified as nucleoside metabolic inhibitor, per the FDA's Established Pharmacologic Class.
Is Depocyt FDA-registered?
Depocyt is on record with the U.S. FDA under application number NDA021041. You can verify this on its official FDA label.
Has Depocyt been recalled by the FDA?
Depocyt has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
Is Depocyt safe?
There's no single safe-or-not verdict. pharmaranks gives Depocyt a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.

Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

People also viewed

Compare Depocyt head-to-head

More nucleoside metabolic inhibitor drugs

Identify a pill by its imprint →Check a drug interaction →Drug recalls →

Browse medications A–Z

Research products from A to Z, compare independent ratings, and find alternatives.